
    
      The study is an open label, multicentric clinical trial. Collected data are managed by the
      DACIMA Clinical SuiteÂ®, the electronic data capture platform which complies with the FDA 21
      CFR part 11 requirements (Food and Drug Administration 21 Code of Federal Regulations part
      11), the HIPAA specifications (Health Insurance Portability and Accountability Act), and the
      ICH standards (International Conference on Harmonisation).
    
  